Prolyt

product on market Capsule Village Green Pathway Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 50% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This profile features bromelain, trypsin, and turmeric, which have moderate evidence for supporting inflammatory responses. Quercetin and grape seed extract provide antioxidant properties, though overall clinical evidence for this specific combination is limited. The ingredients are generally well-tolerated with a high safety score.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Prolyt
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
50
Servings
Other Combinations
Product Type
50%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

300 mg
Market median: 200.0mg (136 products) 3 studies — no high-quality reviews
Trypsin
200 mg
150 mg
Market median: 450.0mg (254 products) 243 studies (A:0, B:100)
100 mg
Market median: 500.0mg (283 products) 174 studies (A:0, B:62)
Market median: 100.0mg (284 products) 10 studies (A:0, B:4)
Chymotrypsin
5 mg

Other Ingredients

HPMC Calcium Carbonate Microcrystalline Cellulose Stearic Acid Magnesium Stearate Silica
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

DIRECTIONS: As a dietary supplement take 1-2 capsules two times daily away from food, or as directed by a health professional.

Warnings & Precautions

Contains: Milk.

KEEP OUT OF REACH OF CHILDREN

Formulation Notes

Full Strength Proteolytic Enzymes with Synergistic Bioflavonoids**

Contains: Milk.

THIS PRODUCT DOES NOT CONTAIN: wheat, rye, oats, soy, gluten, yeast, egg, preservatives.

Additional Information

Same Trusted PATHWAY Formula

STORE IN A COOL, DRY PLACE

REV.092513 053837-02

Metadata

Product Details

UPC / SKU2728
DSLD Entry Date2014-06-25
Product TypeOther Combinations
FormCapsule
DSLD ID34182
Data Updated2026-04-11
Research

Research Evidence

1
Research Sources
52
Avg Quality
1
Systematic Review
C The role of Bromelain and Liposomal Vitamin C in the treatment of chronic venous disease
Systematic Review VASA. Zeitschrift fur Gefasskrankheiten 2025 PubMed DOI
View all evidence for Bromelain →
Compare

Similar Products

View all Bromelain products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.